New Publication: clinical data demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC
Photocure ASA, The Bladder Cancer Company, announces the publication of the study "The Impact of Blue Light Cystoscopy Use Among Non-Muscle Invasive Bladder Cancer Patients in an Equal... | May 4, 2023
San Francisco United States United States Veterans Affairs Healthcare System Veterans Affairs Bladder Cancer Company Equal Access Setting
Source: marketscreener.com